Suspension of trading

Income Statement Amedisys

Stocks

AMED

US0234361089

Market Closed - Nasdaq Other stock markets 16:00:00 2025-08-14 EDT			5-day change	1st Jan Change
100.99 ^USD	+0.01%		-.--%	-

04-28	SnapMedTech, Inc. acquired connectRN Inc.	CI
25-09-30	Cornerstone Healthcare, Inc. and Tensaw River Healthcare LLC completed the acquisition of Equity Interests and Assets of Subsidiaries of UnitedHealth Group Incorporated, Amedisys, Inc. and certain other sellers.	CI

ca1dbda132c49c3bf.sNza4_ma5PDOvKzWQxy66UmNePQP75xx4EdK6ISzgVg._6mVhrrwr6-_19qBGVf-nXz1La04jP4noX4eq_fm4izDnrOlqdOKlZvQ4Q

Published financial data: AMEDISYS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2.07B	2.21B	2.22B	2.24B	2.35B
Total Revenues	2.07B	2.21B	2.22B	2.24B	2.35B
Cost of Goods Sold, Total	1.61B	1.22B	1.26B	1.25B	1.33B
Gross Profit	461M	994M	963M	991M	1.02B
Selling General & Admin Expenses, Total	219M	711M	754M	780M	790M
Depreciation & Amortization - (IS)	28.8M	30.9M	24.94M	17.75M	18M
Other Operating Expenses, Total	248M	742M	779M	798M	808M
Operating Income	213M	252M	184M	193M	210M
Interest Expense, Total	-11.04M	-9.52M	-22.23M	-31.27M	-30.76M
Interest And Investment Income	292K	49K	178K	3.27M	8.11M
Net Interest Expenses	-10.75M	-9.48M	-22.05M	-28M	-22.65M
Income (Loss) On Equity Invest.	3.97M	36.05M	-45K	10.76M	6.27M
Other Non Operating Income (Expenses)	1.31M	1.74M	1.57M	6.47M	8.06M
EBT, Excl. Unusual Items	208M	280M	163M	182M	201M
Restructuring Charges	-5M	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-36.67M	-66.64M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-2.98M	-	-3.01M	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-4.15M	-	-	-	-48.39M
Legal Settlements	-	-	-	-	-
Other Unusual Items	15.37M	300K	-	-106M	-
EBT, Incl. Unusual Items	211M	280M	160M	39.62M	86.22M
Income Tax Expense	25.64M	70.06M	42.54M	50.56M	48.05M
Earnings From Continuing Operations	185M	210M	118M	-10.94M	38.16M
Net Income to Company	185M	210M	118M	-10.94M	38.16M
Minority Interest	-1.58M	-1.09M	910K	1.19M	5.07M
Net Income - (IS)	184M	209M	119M	-9.75M	43.23M
Net Income to Common Incl Extra Items	184M	209M	119M	-9.75M	43.23M
Net Income to Common Excl. Extra Items	184M	209M	119M	-9.75M	43.23M
Per Share Items
Net EPS - Basic	5.64	6.4	3.65	-0.3	1.32
Basic EPS - Continuing Operations	5.64	6.4	3.65	-0.3	1.32
Basic Weighted Average Shares Outstanding	32.56M	32.64M	32.52M	32.6M	32.72M
Net EPS - Diluted	5.52	6.34	3.63	-0.3	1.31
Diluted EPS - Continuing Operations	5.52	6.34	3.63	-0.3	1.31
Diluted Weighted Average Shares Outstanding	33.27M	32.97M	32.65M	32.6M	33.05M
Normalized Basic EPS	3.94	5.33	3.17	3.53	4
Normalized Diluted EPS	3.85	5.27	3.15	3.53	3.96
Supplemental Items
EBITDA	242M	283M	209M	217M	236M
EBITA	230M	270M	197M	199M	214M
EBIT	213M	252M	184M	193M	210M
EBITDAR	283M	326M	256M	254M	274M
Effective Tax Rate - (Ratio)	12.16	25	26.55	127.6	55.74
Current Domestic Taxes	52.2M	25.5M	19.2M	29.9M	40.7M
Total Current Taxes	52.2M	25.5M	19.2M	29.9M	40.7M
Deferred Domestic Taxes	-26.6M	44.6M	23.3M	20.7M	7.4M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-26.6M	44.6M	23.3M	20.7M	7.4M
Normalized Net Income	128M	174M	103M	115M	131M
Interest on Long-Term Debt	11.04M	9.52M	22.23M	31.27M	30.76M
Supplemental Operating Expense Items
Advertising Expense	8M	7.4M	7.3M	7.2M	7.4M
General and Administrative Expenses	219M	237M	245M	264M	260M
Research And Development Expense From Footnotes	-	1.2M	3M	3.8M	4.5M
Net Rental Expense, Total	41.6M	43.6M	47.3M	37.5M	38.7M
Imputed Operating Lease Interest Expense	11.6M	7.79M	15.52M	18.3M	20.13M
Imputed Operating Lease Depreciation	30M	35.81M	31.78M	19.2M	18.57M
Stock-Based Comp., G&A Exp. (Total)	26.73M	23.9M	16.56M	26.08M	29.03M
Stock-Based Comp., Other (Total)	-	-	-	2.94M	1.61M
Total Stock-Based Compensation	26.73M	23.9M	16.56M	29.02M	30.64M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	81.81M	42.69M	40.54M	126M	303M
Total Cash And Short Term Investments	81.81M	42.69M	40.54M	126M	303M
Accounts Receivable, Total	255M	275M	297M	313M	296M
Other Receivables	2.5M	12.1M	12.4M	14.8M	10.2M
Total Receivables	258M	287M	309M	328M	306M
Prepaid Expenses	10.22M	10.36M	11.63M	14.64M	13.07M
Restricted Cash	1.55M	3.08M	13.59M	12.41M	-
Other Current Assets, Total	10.76M	13.5M	14.02M	15.26M	9.49M
Total Current Assets	362M	357M	389M	497M	632M
Gross Property Plant And Equipment	212M	217M	220M	223M	225M
Accumulated Depreciation	-95M	-96.9M	-101M	-92.4M	-101M
Net Property Plant And Equipment	117M	120M	119M	131M	124M
Long-term Investments	14.2M	53.1M	60.5M	66.1M	69.8M
Goodwill	933M	1.2B	1.29B	1.24B	1.21B
Other Intangibles, Total	74.18M	111M	101M	103M	81.16M
Deferred Tax Assets Long-Term	47.99M	289K	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	19M	19.92M	19.34M	19M	18.18M
Total Assets	1.57B	1.86B	1.98B	2.06B	2.14B
Liabilities
Accounts Payable, Total	42.67M	38.22M	43.74M	28.24M	39.96M
Accrued Expenses, Total	235M	235M	200M	330M	411M
Current Portion of Long-Term Debt	8.8M	12.1M	14.3M	22.51M	22.47M
Current Portion of Leases	31.75M	32.13M	34.72M	40.09M	41.41M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	11.6M	-	-	-	-
Other Current Liabilities	126M	57M	63.2M	52.9M	-
Total Current Liabilities	456M	374M	356M	474M	514M
Long-Term Debt	204M	431M	418M	347M	325M
Long-Term Leases	62.89M	70.01M	70.6M	77.85M	70.11M
Deferred Tax Liability Non Current	-	-	20.41M	40.64M	48.05M
Other Non Current Liabilities	33.62M	4.98M	4.81M	1.42M	882K
Total Liabilities	756M	881M	870M	940M	959M
Common Stock, Total	38K	38K	38K	38K	38K
Additional Paid In Capital	698M	728M	755M	787M	818M
Retained Earnings	430M	639M	758M	748M	791M
Treasury Stock	-319M	-436M	-461M	-469M	-475M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	809M	931M	1.05B	1.07B	1.13B
Minority Interest	1.52M	44.97M	55M	53.27M	45.42M
Total Equity	811M	976M	1.11B	1.12B	1.18B
Total Liabilities And Equity	1.57B	1.86B	1.98B	2.06B	2.14B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	32.85M	32.53M	32.55M	32.67M	38.37M
ECS Total Common Shares Outstanding	32.81M	32.51M	32.52M	32.67M	32.78M
Book Value / Share	24.66	28.65	32.34	32.65	34.61
Tangible Book Value	-198M	-376M	-337M	-281M	-161M
Tangible Book Value Per Share	-6.02	-11.56	-10.36	-8.6	-4.9
Total Debt	307M	546M	538M	487M	459M
Net Debt	225M	503M	497M	361M	156M
Debt Equivalent Oper. Leases	333M	349M	378M	300M	310M
Minority Interest, Total (Incl. Fin. Div)	1.52M	44.97M	55M	53.27M	45.42M
Equity Method Investments, Total	14.2M	53.1M	40.5M	46.1M	49.8M
Account Code - Inventory Valuation	3	3	3	3	3
Buildings, Total	9M	9.1M	9.7M	11M	-
Machinery, Total	53.12M	54.74M	56.93M	40.04M	78.61M
Full Time Employees	21K	21K	20K	19K	19K
Assets under Capital Lease - Gross	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	184M	209M	119M	-9.75M	43.23M
Depreciation & Amortization - CF	50.84M	52.66M	55.36M	51.94M	55.76M
Amortization of Goodwill and Intangible Assets - (CF)	16.6M	18.5M	13.5M	5.7M	4.7M
Depreciation & Amortization, Total	67.44M	71.16M	68.86M	57.64M	60.46M
Amortization of Deferred Charges, Total - (CF)	869K	917K	991K	991K	991K
(Gain) Loss From Sale Of Asset	-30K	-124K	519K	2.5M	-1.65M
(Gain) Loss on Sale of Investments - (CF)	2.98M	-31.1M	-	-	-
Asset Writedown & Restructuring Costs	4.65M	100K	5.11M	200K	48.39M
(Income) Loss On Equity Investments - (CF)	1.48M	394K	5.21M	-5.69M	-2.64M
Stock-Based Compensation (CF)	26.73M	23.81M	16.56M	29.02M	30.64M
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	-25M	45.68M	22.47M	125M	2.35M
Change In Accounts Receivable	2.11M	-18.03M	-14.23M	-26.73M	16.48M
Change In Accounts Payable	1.94M	-4.35M	4.89M	-15.82M	12.21M
Change in Other Net Operating Assets	22.17M	-109M	-95.71M	-20.66M	11.21M
Cash from Operations	289M	189M	133M	137M	222M
Capital Expenditure	-5.33M	-6.3M	-6.16M	-5.62M	-6.55M
Sale of Property, Plant, and Equipment	80K	144K	66K	136K	-
Cash Acquisitions	-299M	-270M	-71.95M	-350K	-
Divestitures	-	-	-	47.79M	-
Sale (Purchase) of Intangible assets	-	-419K	-1.05M	-7.09M	-823K
Investment in Marketable and Equity Securities, Total	17M	-5.2M	-15.64M	150K	-1.05M
Other Investing Activities, Total	101K	135K	252K	54K	55K
Cash from Investing	-287M	-282M	-94.49M	35.06M	-8.36M
Long-Term Debt Issued, Total	684M	791M	534M	23M	-
Total Debt Issued	684M	791M	534M	23M	-
Long-Term Debt Repaid, Total	-713M	-561M	-548M	-99.01M	-37.36M
Total Debt Repaid	-713M	-561M	-548M	-99.01M	-37.36M
Issuance of Common Stock	9.89M	6.02M	6.15M	2.7M	309K
Repurchase of Common Stock	-54.49M	-117M	-25.33M	-6.53M	-6.15M
Other Financing Activities, Total	58.88M	-64.29M	2.04M	-7.68M	-5.72M
Cash from Financing	-14.98M	55.13M	-30.43M	-87.52M	-48.92M
Net Change in Cash	-13.13M	-37.59M	8.36M	84.73M	164M
Supplemental Items
Cash Interest Paid	6.21M	5.29M	27.69M	29.77M	29.99M
Cash Income Tax Paid (Refund)	50.72M	34.1M	24.01M	29.13M	40.1M
Levered Free Cash Flow	383M	121M	122M	259M	278M
Unlevered Free Cash Flow	389M	126M	135M	277M	296M
Change In Net Working Capital	-167M	120M	57.97M	-82.54M	-81.04M
Net Debt Issued / Repaid	-29.25M	230M	-13.3M	-76.01M	-37.36M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.41	9.19	5.99	5.98	6.24
Return on Total Capital	12.77	11.91	7.26	7.42	8.07
Return On Equity %	25.5	23.52	11.3	-0.98	3.32
Return on Common Equity	25.33	24.02	11.96	-0.92	3.93
Margin Analysis
Gross Profit Margin %	22.24	44.88	43.31	44.31	43.34
SG&A Margin	10.56	32.12	33.92	34.88	33.65
EBITDA Margin %	11.68	12.76	9.39	9.7	10.03
EBITA Margin %	11.09	12.2	8.87	8.89	9.12
EBIT Margin %	10.28	11.36	8.27	8.63	8.92
Income From Continuing Operations Margin %	8.94	9.49	5.29	-0.49	1.62
Net Income Margin %	8.86	9.44	5.34	-0.44	1.84
Net Avail. For Common Margin %	8.86	9.44	5.34	-0.44	1.84
Normalized Net Income Margin	6.19	7.85	4.63	5.15	5.57
Levered Free Cash Flow Margin	18.47	5.47	5.5	11.56	11.82
Unlevered Free Cash Flow Margin	18.76	5.69	6.08	12.39	12.59
Asset Turnover
Asset Turnover	1.46	1.29	1.16	1.11	1.12
Fixed Assets Turnover	18.01	18.7	18.64	17.91	18.46
Receivables Turnover (Average Receivables)	8.41	8.35	7.78	7.33	7.71
Short Term Liquidity
Current Ratio	0.79	0.95	1.09	1.05	1.23
Quick Ratio	0.74	0.88	0.98	0.96	1.18
Operating Cash Flow to Current Liabilities	0.63	0.5	0.37	0.29	0.43
Days Sales Outstanding (Average Receivables)	43.53	43.69	46.93	49.79	47.49
Average Days Payable Outstanding	8.4	12.1	11.87	10.55	9.38
Long Term Solvency
Total Debt/Equity	37.87	55.88	48.61	43.51	38.92
Total Debt / Total Capital	27.47	35.85	32.71	30.32	28.02
LT Debt/Equity	32.87	51.35	44.18	37.92	33.51
Long-Term Debt / Total Capital	23.84	32.94	29.73	26.42	24.12
Total Liabilities / Total Assets	48.27	47.42	44.01	45.65	44.83
EBIT / Interest Expense	19.3	26.42	8.27	6.17	6.81
EBITDA / Interest Expense	25.68	34.24	11.52	8.13	8.92
(EBITDA - Capex) / Interest Expense	25.2	33.58	11.24	7.96	8.7
Total Debt / EBITDA	1.08	1.67	2.1	1.92	1.67
Net Debt / EBITDA	0.79	1.54	1.94	1.42	0.57
Total Debt / (EBITDA - Capex)	1.1	1.71	2.15	1.96	1.72
Net Debt / (EBITDA - Capex)	0.81	1.57	1.99	1.45	0.58
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.93	6.88	0.41	0.59	5.01
Gross Profit, 1 Yr. Growth %	12.14	9.79	-1.83	2.92	2.7
EBITDA, 1 Yr. Growth %	22.54	19.28	-22.56	3.93	8.62
EBITA, 1 Yr. Growth %	23.64	20.24	-23.27	0.75	7.8
EBIT, 1 Yr. Growth %	19.06	20.94	-22.98	5.05	8.55
Earnings From Cont. Operations, 1 Yr. Growth %	44.78	13.49	-44	-109.29	-448.96
Net Income, 1 Yr. Growth %	44.76	13.87	-43.27	-108.22	-543.53
Normalized Net Income, 1 Yr. Growth %	20.51	41.15	-37.89	11.83	13.66
Diluted EPS Before Extra, 1 Yr. Growth %	43.75	14.86	-42.74	-108.26	-536.67
Accounts Receivable, 1 Yr. Growth %	7.39	7.77	7.94	5.59	-5.52
Net Property, Plant and Equip., 1 Yr. Growth %	3.77	2.16	-0.68	10.01	-5.49
Total Assets, 1 Yr. Growth %	24.11	18.49	6.42	4.25	3.81
Tangible Book Value, 1 Yr. Growth %	138.71	90.21	-10.36	-16.66	-42.85
Common Equity, 1 Yr. Growth %	26.35	15.09	12.91	1.42	6.38
Cash From Operations, 1 Yr. Growth %	43.05	-34.63	-29.44	2.93	61.58
Capital Expenditures, 1 Yr. Growth %	-32.4	18.19	-2.17	-8.84	16.55
Levered Free Cash Flow, 1 Yr. Growth %	179.66	-68.11	8.33	111.63	7.31
Unlevered Free Cash Flow, 1 Yr. Growth %	168.01	-67.3	14.65	105.16	6.7
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.62	6.4	3.6	0.5	2.78
Gross Profit, 2 Yr. CAGR %	14.21	11.09	4.23	0.51	2.81
EBITDA, 2 Yr. CAGR %	19.84	19.64	-2.12	-10.29	6.25
EBITA, 2 Yr. CAGR %	21.66	22.86	2.15	-8.73	7.98
EBIT, 2 Yr. CAGR %	17.18	18.58	-1.4	-10.05	6.79
Earnings From Cont. Operations, 2 Yr. CAGR %	24.16	28.18	-20.28	-77.19	-43.06
Net Income, 2 Yr. CAGR %	24.03	28.39	-19.63	-78.41	-39.63
Normalized Net Income, 2 Yr. CAGR %	14.02	27.86	-3.83	-16.66	12.74
Diluted EPS Before Extra, 2 Yr. CAGR %	24.7	28.49	-18.91	-78.25	-39.93
Accounts Receivable, 2 Yr. CAGR %	16.2	7.58	7.85	6.76	-0.12
Net Property, Plant and Equip., 2 Yr. CAGR %	99.46	2.96	0.73	4.53	1.97
Total Assets, 2 Yr. CAGR %	47.83	21.27	12.29	5.33	4.03
Tangible Book Value, 2 Yr. CAGR %	35.3	113.08	30.58	-13.57	-30.99
Common Equity, 2 Yr. CAGR %	29.63	20.59	13.99	7.01	3.87
Cash From Operations, 2 Yr. CAGR %	13.71	-3.3	-32.08	-14.78	28.96
Capital Expenditures, 2 Yr. CAGR %	-9.83	-10.62	7.53	-5.57	3.08
Levered Free Cash Flow, 2 Yr. CAGR %	52.71	-6.24	-42.38	51.35	50.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	52.15	-7.03	-39.91	53.3	47.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.08	10.02	4.37	2.59	1.98
Gross Profit, 3 Yr. CAGR %	14.74	41.17	6.13	3.79	1.24
EBITDA, 3 Yr. CAGR %	23.54	18.82	1.88	-0.14	-4.38
EBITA, 3 Yr. CAGR %	27.36	20.3	3.31	1.68	-3.52
EBIT, 3 Yr. CAGR %	24.22	17.49	0.89	0.7	-4.23
Earnings From Cont. Operations, 3 Yr. CAGR %	82.07	20.5	-2.73	-61.06	-43.37
Net Income, 3 Yr. CAGR %	82.31	20.55	-2.21	-62.42	-40.87
Normalized Net Income, 3 Yr. CAGR %	22.77	20.82	-1.08	1.13	-7.58
Diluted EPS Before Extra, 3 Yr. CAGR %	84.42	21.33	-1.86	-62.12	-40.88
Accounts Receivable, 3 Yr. CAGR %	8.24	13.32	7.7	7.09	2.5
Net Property, Plant and Equip., 3 Yr. CAGR %	55.56	59.59	1.73	3.74	1.08
Total Assets, 3 Yr. CAGR %	24.43	37.32	16.1	9.55	4.82
Tangible Book Value, 3 Yr. CAGR %	9.8	51.57	59.66	12.42	-24.7
Common Equity, 3 Yr. CAGR %	16.23	24.59	17.97	9.64	6.8
Cash From Operations, 3 Yr. CAGR %	39.81	-5.45	-12.94	-21.99	5.48
Capital Expenditures, 3 Yr. CAGR %	-20.74	-1.32	-7.89	1.77	1.29
Levered Free Cash Flow, 3 Yr. CAGR %	64	-9.65	-3.89	-11.1	34.96
Unlevered Free Cash Flow, 3 Yr. CAGR %	63.35	-9.11	-2.52	-9.52	35.86
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.34	9.3	8.03	6.11	3.73
Gross Profit, 5 Yr. CAGR %	12.02	29.03	25.85	22.91	4.79
EBITDA, 5 Yr. CAGR %	22.37	28.24	10.22	5.19	3.61
EBITA, 5 Yr. CAGR %	27.52	33.26	12.16	5.08	3.67
EBIT, 5 Yr. CAGR %	25.62	32.43	10.58	4.47	3.21
Earnings From Cont. Operations, 5 Yr. CAGR %	140.28	41.06	30.85	-38.08	-21.49
Net Income, 5 Yr. CAGR %	127.38	41.19	31.38	-39.41	-19.37
Normalized Net Income, 5 Yr. CAGR %	23.41	34.41	8.25	3.15	4.23
Diluted EPS Before Extra, 5 Yr. CAGR %	127.04	41.95	32.77	-38.99	-19.35
Accounts Receivable, 5 Yr. CAGR %	15.34	10.61	8.08	10.65	4.5
Net Property, Plant and Equip., 5 Yr. CAGR %	22.37	26.47	30.74	34.74	1.83
Total Assets, 5 Yr. CAGR %	18.11	20.4	19.43	23.5	11.11
Tangible Book Value, 5 Yr. CAGR %	13.73	24.74	17.68	21.07	14.15
Common Equity, 5 Yr. CAGR %	14.59	15.14	15.33	17.24	12.12
Cash From Operations, 5 Yr. CAGR %	21.8	24.85	4.74	-9.3	1.88
Capital Expenditures, 5 Yr. CAGR %	-24.29	-16.7	-10.45	-3.04	-3.65
Levered Free Cash Flow, 5 Yr. CAGR %	47.15	30.2	7.09	9.53	15.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	45.93	29.34	8.67	10.55	15.19